COMBINATION THERAPY OF VEDOLIZUMAB AND A TNF ANTAGONIST IN IBD PATIENTS WITH SEVERE CHRONIC ACTIVE, THERAPY REFRACTORY DISEASE COURSE

被引：1
|
作者：
Kuehbacher, Tanja
AbuHashem, Raed
Langel, Natalie
Schreiber, Stefan
Drvarov, Oliver
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31568-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1933
引用
收藏
页码：S398 / S398
页数：1
相关论文
共 50 条
  • [41] The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn's Disease
    Macaluso, F. S.
    Grova, M.
    Saladino, M.
    Demarzo, M. G.
    Privitera, A. C.
    Giangreco, E.
    Garufi, S.
    Renna, S.
    Casa, A.
    Ventimiglia, M.
    Cappello, M.
    Fries, W.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I359 - I359
  • [42] The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn's Disease
    Macaluso, F. S.
    Grova, M.
    Saladino, M.
    Demarzo, M. G.
    Privitera, A. C.
    Giangreco, E.
    Garufi, S.
    Renna, S.
    Casa, A.
    Ventimiglia, M.
    Cappello, M.
    Fries, W.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I359 - I359
  • [43] Distinct Serum Proteome Alterations Following Vedolizumab and Ustekinumab Therapy in IBD Patients
    Saliutina, M.
    Cancino, C.
    Juhran, K. S.
    Fritz, K.
    Eleftheriadou, A. M.
    Blazquez, L. Velasco
    Konopka, A.
    Luo, Y.
    Weidinger, C.
    Sonnenberg, E.
    Siegmund, B.
    Hegazy, A. N.
    Charite IBD Group
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i432 - i432
  • [44] Attempted Salvage Therapy Through Inpatient Initiation of Vedolizumab in Two Patients With Refractory Active Ulcerative Colitis
    Sullivan, Matthew J.
    Blanco, Paola
    Shah, Shashin
    Shah, Hiral
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S297 - S297
  • [45] Potential Role of Exosomes in Countering Vedolizumab-Based Therapy in IBD Patients
    Domenis, Rossana
    Cifu, Adriana
    Fabris, Martina
    Scardino, Giulia
    Zilli, Maurizio
    Marino, Marco
    Curcio, Francesco
    FASEB JOURNAL, 2019, 33
  • [46] ANTI-TNF THERAPY IN SEVERE AND REFRACTORY SARCOIDOSIS: MULTICENTER STUDY OF 25 PATIENTS
    Perez-Martin, I.
    Blanco, R.
    Ortego, N.
    Llorens-Belles, V.
    Adan, A.
    Olive, A.
    Sifuentes Giraldo, W. A.
    Gonzalez, S.
    Bejerano, C.
    Gonzalez-Vela, M. C.
    Gonzalez-Lopez, M. A.
    Fernandez-Llaca, H.
    Oterino, A.
    Sedano, M. J.
    Agudo, M.
    Corrales, A.
    Martinez-Taboada, V. M.
    Gonzalez-Gay, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 287 - 288
  • [47] THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN'S DISEASE
    Macaluso, F. S.
    Grova, M.
    Saladino, M.
    Demarzo, M. G.
    Privitera, A. C.
    Giangreco, E.
    Garufi, S.
    Renna, S.
    Casa, A.
    Ventimiglia, M.
    Cappello, M.
    Fries, W.
    Orlando, A.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S93 - S94
  • [48] Belumosudil Combination Therapy in Refractory Chronic Graft-Versus-Host Disease
    Chin, Michelle
    Shizuru, Judith A.
    Muffly, Lori
    Shiraz, Parveen
    Johnston, Laura J.
    Lowsky, Robert
    Rezvani, Andrew R.
    Frank, Matthew J.
    Bharadwaj, Sushma
    Weng, Wen-Kai
    Negrin, Robert S.
    Miklos, David B.
    Arai, Sally
    BLOOD, 2022, 140 : 4788 - 4789
  • [49] Postoperative disease course after appendectomy as experimental treatment for patients with therapy refractory moderate to severe ulcerative colitis
    Reijntjes, M.
    Heuthorst, L.
    Stellingwerf, M.
    d'Haens, G. R.
    Bemelman, W. A.
    Buskens, C. J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 602 - 603
  • [50] COMPARISON OF SHORT AND LONG-TERM EFFICACY BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN PATIENTS WITH CROHN'S DISEASE REFRACTORY TO ANTI-TNF THERAPY
    Manlay, Luc
    Boschetti, Gilles
    Pereira, Bruno
    Buisson, Anthony
    Nancey, Stephane
    GASTROENTEROLOGY, 2021, 160 (06) : S6 - S6
12345